371 - Itolizumab, a Novel Targeted Anti-CD6 Therapy, Induces Cleavage of Cell Surface CD6 and Rapid Onset of Efficacy in Subjects with Newly Diagnosed Acute Graft-Versus-Host Disease
Saved in:
Published in | Transplantation and cellular therapy Vol. 28; no. 3; pp. S287 - S288 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
01.03.2022
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 2666-6367 2666-6367 |
---|---|
DOI: | 10.1016/S2666-6367(22)00531-0 |